Preventive Medicine News

Although daptomycin remains more expensive than vancomycin, it is a “suitable alternative” to daptomycin for outpatient parenteral antimicrobial therapy because it results in less health care utilization, researchers reported.

Individuals with unhealthy lifestyles may derive the most benefit from aspirin for colorectal cancer prevention, according to results of a prospective cohort study.

In March, Puerto Rico declared a public health emergency after recording 549 cases of dengue virus since the start of 2024. The number rose to more than 1,900 cases as of July 24, when the CDC issued a health alert for the United States.

One of the greatest milestones in a family physician’s career is the first time a patient asks you to be their primary care physician.

Using the American Heart Association’s new PREVENT risk calculator would mean reducing eligibility for statin and/or antihypertensive therapy by approximately 16 million U.S. adults, researchers reported in JAMA.

Testing HIV PrEP users for STIs every 6 months did not increase the risk for STIs compared with testing them every 3 months and could reduce the cost of PrEP programs, according to a study.

Three-quarters of people globally living with HIV are on ART, a roughly 30% increase during the last nine years, and fewer people acquired HIV in 2023 than at any point since the late 1980s, UNAIDS reported.

Informing patients of the benefit-harm balance associated with mammography screening is beneficial and did not hinder overall screening decisions, according to results of a national probability-based U.S. survey.

Researchers developed a low-cost rapid test to detect an invasive species of mosquito that has adapted to live near humans in urban environments, which they hope can be used in areas far from medical labs.

The American Heart Association’s PREVENT equations predicted that people with stage 1 hypertension have a lower 10-year risk for atherosclerotic CVD compared with the Pooled Cohort Equations.